Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct;2(10):678-90.
doi: 10.18632/aging.100208.

Intracellular protein glycosylation modulates insulin mediated lifespan in C.elegans

Affiliations

Intracellular protein glycosylation modulates insulin mediated lifespan in C.elegans

Mohammad M Rahman et al. Aging (Albany NY). 2010 Oct.

Abstract

O-linked-β-N-acetylglucosamine (O-GlcNAc) modification is a regulatory, nuclear and cytoplasmic post-translational glycosylation of proteins associated with age-related diseases such as Alzheimer's, Parkinson's, and type II diabetes. Global elevation of O-GlcNAc levels on intracellular proteins can induce insulin resistance, the hallmark of type II diabetes, in mammalian systems. InC. elegans, attenuation of the insulin-like signal transduction pathway increases adult lifespan of the nematode. We demonstrate that the O-GlcNAc cycling enzymes OGT and OGA, which add and remove O-GlcNAc respectively, modulate lifespan in C. elegans. Median adult lifespan is increased in an oga-1 deletion strain while median adult life span is decreased upon ogt-1 deletion. The O-GlcNAc-mediated effect on nematode lifespan is dependent on the FoxO transcription factor DAF-16. DAF-16 is a key factor in the insulin-like signal transduction pathway to regulate reproductive development, lifespan, stress tolerance, and dauer formation in C. elegans. Our data indicates that O-GlcNAc cycling selectively influences only a subset of DAF-16 mediated phenotypes, including lifespan and oxidative stress resistance. We performed an affinity purification of O-GlcNAc-modified proteins and observed that a high percentage of these proteins are regulated by insulin signaling and/or impact insulin pathway functional outcomes, suggesting that the O-GlcNAc modification may control downstream effectors to modulate insulin pathway mediated cellular processes.

PubMed Disclaimer

Conflict of interest statement

The authors of this manuscript have no conflict of interests to declare.

Figures

Figure 6.
Figure 6.
A conserved insulin signaling pathway in C. elegans regulates numerous functions including stress response, metabolism, dauer formation, and reproductive development by restricting the nuclear localization of the DAF-16/FoxO transcription factor upon nutrient availability [45]. Upon ligand binding (top panel), the insulin-like receptor DAF-2 activates the AGE-1 PI3 kinase that facilitates the activation of PDK-1 and AKT-1. AKT-1-mediated phosphorylation sequesters DAF-16 in the cytoplasm. In the absence of PI3K/AKT signaling (bottom panel) DAF-16 enters the nucleus and regulates the expression of target genes to mediate numerous DAF-16 dependent processes, including those listed.
Figure 1.
Figure 1.. Elevated O-GlcNAc levels extend adult lifespan in C. elegans.
(A) The oga-1(ok1207) mutant has an extended adult lifespan while the ogt-1(ok1474) mutant has a reduced lifespan relative to wild-type animals, assayed at 20°C. Lifespan curves are based on pooled data from multiple replicates described in Table 1. (B) OGA-1 and OGT-1 regulate cellular O-GlcNAc-modified protein levels. Western blot of total animal extract from ogt-1(ok1474), wild-type, and oga-1(ok1207) animals probed with antibodies against O-GlcNAc and tubulin showing marked differences in total O-GlcNAcylated protein levels. (C) Lifespan extension in the oga-1 mutant is DAF-16-dependent, as seen in the reduced lifespan of the oga-1(ok1207); daf-16(mu86) double mutant relative to the oga-1(ok1207) single mutant. (D) Loss of O-GlcNAc modification, in the daf-2(e1370); ogt-1(ok1474) double mutant, reduces the extended lifespan of the daf-2(e1370) mutant. Control curves are re-plotted to facilitate comparisons in panels A, C, and D.
Figure 2.
Figure 2.. Elevated O-GlcNAc modification of proteins does not increase adult lifespan further in long-lived insulin signaling pathway mutant animals.
(A and B) Lifespan of age-1(hx546) and sgk-1(ok538) mutants is dependent on protein O-GlcNAc modification as seen in age-1; ogt-1 (A) and sgk-1; ogt-1 (B) double mutants. (C and D) The adult lifespan extension associated with the oga-1(ok1207) mutant is not synergistic or additive with mutations of the long-lived insulin signaling pathway kinase age-1 (C) or sgk-1 (D). Lifespan curves (A-D) are based on pooled data from multiple replicates as described in Table 1. Control curves are re-plotted to facilitate comparisons in panels A-D.
Figure 3.
Figure 3.. Aberrant protein O-GlcNAc cycling modestly enhances DAF-16 nuclear localization.
DAF-16::GFP (translational fusion) nuclear localization in oga-1(RNAi) and ogt-1(RNAi) animals is modestly increased relative to control (vector) RNAi animals but much less than observed in age-1(RNAi) animals (upper panel). Lower panel is the quantification of DAF-16::GFP levels in intestinal cells upon RNAi inactivation of ogt-1, oga-1, age-1, and vector control.
Figure 4.
Figure 4.. Inactivation of O-GlcNAc cycling enzymes only affects a subset of functions regulated by the insulin-like signaling pathway.
(A) The oga-1(ok1207) mutant is resistant to oxidative stress (100mM paraquat for 9 hrs). Notably, the oxidative stress resistance in daf-2(e1370) mutant is significantly reduced in the daf-2(e1370); ogt-1(ok1474) double mutant, suggesting that protein O-GlcNAc modification contributes to the oxidative resistance of the daf-2 mutant. (B) The long-lived oga-1(ok1207) mutant is sensitive to heat stress (35°C), unlike the long-lived daf-2 (e1370) mutant. (C) oga-1 and ogt-1 mutants have normal developmental timing [from hatch to the fourth larval molt] at 20°C. The daf-2 mutant has delayed post-embryonic development, and this delay is unaffected by loss of O-GlcNAc modification in the daf-2; ogt-1 double mutant. (D) oga-1 and ogt-1 mutants generate normal numbers of offspring while the daf-2 mutant has reduced fecundity at 20°C. The reduced fecundity in the daf-2 mutant is not rescued by loss of O-GlcNAc modification in the daf-2; ogt-1 double mutant. Asterisks above bars denote statistically significant differences from wild type (* p < 0.05 and ** p < 0.01); while asterisks above solid lines connecting two genotypes denote statistically significant differences between those genotypes.
Figure 5.
Figure 5.. Aberrant protein O-GlcNAc cycling differentially affects distinct stress response pathways in C. elegans.
(A) Images and quantification of sod-3::GFP reporter expression upon inactivation of OGA-1 and the insulin pathway effector kinase AGE-1. (B) Images and quantification of hsp-16-2::GFP reporter expression upon inactivation of OGA-1 and AGE-1. Note that inactivation of AGE-1 by RNAi induces both SOD-3 and HSP-16 expression, while OGA-1 inactivation only induces SOD-3 expression. Asterisks denote statistically significant differences from vector RNAi controls (* p < 0.05 and ** p < 0.01).

Comment in

Similar articles

Cited by

References

    1. Biddinger SB, Kahn CR. From mice to men: insights into the insulin resistance syndromes. Annual review of physiology. 2006;68:123–158. - PubMed
    1. Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. The Journal of biological chemistry. 1991;266:4706–4712. - PubMed
    1. Wells L, Vosseller K, Hart GW. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science. 2001;291:2376–2378. - PubMed
    1. Hart GW, Housley MP, Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature. 2007;446:1017–1022. - PubMed
    1. Dias WB, Hart GW. O-GlcNAc modification in diabetes and Alzheimer's disease. Mol Biosyst. 2007;3:766–772. - PubMed

Publication types

MeSH terms

Substances